Matches in SemOpenAlex for { <https://semopenalex.org/work/W4296058034> ?p ?o ?g. }
- W4296058034 abstract "Circular RNA (circRNA/circ) profiles have been suggested to be involved in the prognosis of several types of solid tumors and hematological malignancies, including multiple myeloma (MM). Therefore, the aim of the present study was to comprehensively explore the involvement of circRNA profiles in MM prognosis. A total of 60 patients with MM that underwent bortezomib‑based induction therapy were enrolled. Next, eight patients with complete response (CR) and eight with no response (NR) were randomly selected to detect their circRNA profiles in bone marrow plasma cells (BMPCs) by microarray. Next, 10 candidate circRNAs were verified via reverse transcription‑quantitative PCR (RT‑qPCR) in the BMPCs of 60 patients with MM. Finally, the molecular mechanism of circ_0026652 knockdown underlying the regulation of chemosensitivity to bortezomib was assessed. Microarray showed that 79 circRNAs were upregulated and 167 were downregulated in CR compared with NR cases, which were found to be enriched in carcinogenic and chemoresistance‑related pathways (Wnt, mTOR and MAPK pathways). RT‑qPCR showed that 8/10 circRNAs (circ_0026652, circ_0068708, circ_0088128, circ_0001566, circ_0031113, circ_0083587, circ_0005552 and circ_0007171) were associated with treatment response [CR or objective response rate (ORR)] and 5/10 circRNAs (circ_0026652, circ_0068708, circ_0001566, circ_0031113 and circ_0005552) were associated with progression‑free survival (PFS) or overall survival (OS). Of note, circ_0026652 was a key prognostic marker simultaneously associated with CR, ORR, PFS and OS. Cellular experiments showed that circ_0026652 knockdown enhanced chemosensitivity to bortezomib through the microRNA (miR)‑608‑mediated Wnt/β‑catenin pathway in U266 and RPIM‑8226 cells. In conclusion, dysregulated circRNA profiles were closely associated with MM prognosis, with circ_0026652 being linked to bortezomib‑based treatment response and survival through the miR‑608‑mediated Wnt/β‑catenin pathway." @default.
- W4296058034 created "2022-09-17" @default.
- W4296058034 creator A5000993677 @default.
- W4296058034 creator A5003930369 @default.
- W4296058034 creator A5039117319 @default.
- W4296058034 creator A5041245196 @default.
- W4296058034 creator A5043019475 @default.
- W4296058034 creator A5044036132 @default.
- W4296058034 creator A5047217582 @default.
- W4296058034 creator A5056253982 @default.
- W4296058034 creator A5069469021 @default.
- W4296058034 creator A5077659447 @default.
- W4296058034 creator A5090993474 @default.
- W4296058034 date "2022-09-16" @default.
- W4296058034 modified "2023-10-05" @default.
- W4296058034 title "Dysregulated circular RNAs are closely linked to multiple myeloma prognosis, with circ_0026652 predicting bortezomib‑based treatment response and survival via the microRNA‑608‑mediated Wnt/β‑catenin pathway" @default.
- W4296058034 cites W2003734726 @default.
- W4296058034 cites W2044436186 @default.
- W4296058034 cites W2063355387 @default.
- W4296058034 cites W2101083009 @default.
- W4296058034 cites W2107277218 @default.
- W4296058034 cites W2141038015 @default.
- W4296058034 cites W2144469062 @default.
- W4296058034 cites W2144728882 @default.
- W4296058034 cites W2165974443 @default.
- W4296058034 cites W2168471784 @default.
- W4296058034 cites W2192080449 @default.
- W4296058034 cites W2594477541 @default.
- W4296058034 cites W2613680501 @default.
- W4296058034 cites W2884295034 @default.
- W4296058034 cites W2903734029 @default.
- W4296058034 cites W2906937763 @default.
- W4296058034 cites W2913434193 @default.
- W4296058034 cites W2914684731 @default.
- W4296058034 cites W2921094086 @default.
- W4296058034 cites W2946912486 @default.
- W4296058034 cites W2953225943 @default.
- W4296058034 cites W2956834551 @default.
- W4296058034 cites W2967043226 @default.
- W4296058034 cites W2980785482 @default.
- W4296058034 cites W2983528536 @default.
- W4296058034 cites W2998090839 @default.
- W4296058034 cites W2999705124 @default.
- W4296058034 cites W3004624445 @default.
- W4296058034 cites W3006341638 @default.
- W4296058034 cites W3011856875 @default.
- W4296058034 cites W3014973780 @default.
- W4296058034 cites W3032893790 @default.
- W4296058034 cites W3042151980 @default.
- W4296058034 cites W3181238417 @default.
- W4296058034 cites W3199396470 @default.
- W4296058034 cites W4211037848 @default.
- W4296058034 cites W4225247849 @default.
- W4296058034 cites W2982545021 @default.
- W4296058034 doi "https://doi.org/10.3892/or.2022.8410" @default.
- W4296058034 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36129153" @default.
- W4296058034 hasPublicationYear "2022" @default.
- W4296058034 type Work @default.
- W4296058034 citedByCount "3" @default.
- W4296058034 countsByYear W42960580342023 @default.
- W4296058034 crossrefType "journal-article" @default.
- W4296058034 hasAuthorship W4296058034A5000993677 @default.
- W4296058034 hasAuthorship W4296058034A5003930369 @default.
- W4296058034 hasAuthorship W4296058034A5039117319 @default.
- W4296058034 hasAuthorship W4296058034A5041245196 @default.
- W4296058034 hasAuthorship W4296058034A5043019475 @default.
- W4296058034 hasAuthorship W4296058034A5044036132 @default.
- W4296058034 hasAuthorship W4296058034A5047217582 @default.
- W4296058034 hasAuthorship W4296058034A5056253982 @default.
- W4296058034 hasAuthorship W4296058034A5069469021 @default.
- W4296058034 hasAuthorship W4296058034A5077659447 @default.
- W4296058034 hasAuthorship W4296058034A5090993474 @default.
- W4296058034 hasBestOaLocation W42960580341 @default.
- W4296058034 hasConcept C104317684 @default.
- W4296058034 hasConcept C121608353 @default.
- W4296058034 hasConcept C126322002 @default.
- W4296058034 hasConcept C127561419 @default.
- W4296058034 hasConcept C137620995 @default.
- W4296058034 hasConcept C145059251 @default.
- W4296058034 hasConcept C150194340 @default.
- W4296058034 hasConcept C173396325 @default.
- W4296058034 hasConcept C186836561 @default.
- W4296058034 hasConcept C190283241 @default.
- W4296058034 hasConcept C2775893923 @default.
- W4296058034 hasConcept C2776364478 @default.
- W4296058034 hasConcept C2777478702 @default.
- W4296058034 hasConcept C2781018059 @default.
- W4296058034 hasConcept C29537977 @default.
- W4296058034 hasConcept C502942594 @default.
- W4296058034 hasConcept C54355233 @default.
- W4296058034 hasConcept C62478195 @default.
- W4296058034 hasConcept C71924100 @default.
- W4296058034 hasConcept C86803240 @default.
- W4296058034 hasConceptScore W4296058034C104317684 @default.
- W4296058034 hasConceptScore W4296058034C121608353 @default.
- W4296058034 hasConceptScore W4296058034C126322002 @default.
- W4296058034 hasConceptScore W4296058034C127561419 @default.
- W4296058034 hasConceptScore W4296058034C137620995 @default.
- W4296058034 hasConceptScore W4296058034C145059251 @default.
- W4296058034 hasConceptScore W4296058034C150194340 @default.